Drastic increase in number of heart diseases all over world, cardiovascular disease and peripheral interventions market is expected to get a push; according to a research conducted by Kenneth Research

According the American Heart Association, almost 70.2% of men aged 60 to 79 and 70.9% of women in the United States suffered from heart disease in 2013. This increase in the number of heart diseases is being experienced in present and will be experienced in the future as well. The market of cardiovascular peripheral interventions market is expected to experience growth in the next 10 to 15 years at the rate of almost 10% annually.

The cardiovascular disease and peripheral intervention market is expected to exceed USD 28 billion by 2022, growing at a growth rate of 10% from 2022 to 2030. During anticipated cardiovascular interventions related to catheter technology used to treat heart disease. This includes inserting instruments (which may be catheters, balloons, stents, or other devices) into the femoral artery or large peripheral arteries or veins, and performing X-ray examinations of the heart cannula (called fluoroscopy). In addition, many interventional devices have been used to treat peripheral vascular diseases that can affect blood flow and build up plaque in the arteries of the extremities. Devices on the market include balloons, catheters, guide wires, stents, and filters.

Interventional cardiovascular and peripheral vascular systems are driving lifestyle changes to improve cardiovascular disease, aging, the prevalence of chronic diseases, advances in cardiovascular technology, and better medical infrastructure. The market leads to knowledge. However, the precise verification process of cardiovascular and peripheral vascular interventional devices and the high manufacturing costs of certain devices (for example, absorbable stents and balloons) have limited market development.

Major market players:

Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), Cardinal Health (US), iVascular (Spain), Becton, Dickinson, and Company (US), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Biosensors International Group (Singapore), and BIOTRONIK SE & Co. KG (Germany).

According to the analysis of each market segment, angioplasty stent systems accounted for the largest market share in 2015. This is mainly due to the innovations that led to the development of biotech stents, EPC stent traps and dual therapeutic stents. Stents are also more beneficial than balloon angioplasty because they reduce the risk of plaque buildup and vessel collapse. Therefore, after the expansion operation, a stent is usually placed to ensure continued comfort. Due to population growth and changes in lifestyle, the prevalence of chronic diseases in India is increasing rapidly.

According to the data of the National Laboratory, the incidence of heart failure caused by obesity, coronary heart disease, diabetes, hypertension and rheumatic heart disease in India in 2010 is estimated to be between 1.3 and 4.6 million, and the annual incidence is between 500,000 and 1.8 million. In addition, increasing insurance will make residents more profitable, and the market will continue to grow. This makes India an attractive market for peripheral cardiovascular and vascular interventions. The rapid increase in the number of elderly people around the world, coupled with the increase in the prevalence of chronic diseases, is the market for interventional cardiovascular and peripheral vascular systems. According to the American Heart Association, in 2013, approximately 70.2% of men aged 60 to 79 and 70.9% of women in the United States had heart disease.

Main market regions:
The study on Cardiovascular disease and peripheral intervention market was global in nature and conducted in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa). In addition, areas like Market size, Y-O-Y growth & Opportunity Analysis, market players competitive study, investment opportunities, demand for future outlook etc. have been covered and displayed in the Global Cardiovascular disease and peripheral intervention market research report to ensure it dives deep to achieve strategic competitive intelligence in the segment.

Related posts

Leave a Comment